Lornoxi P Tablet is a combination analgesic and anti-inflammatory medication containing Lornoxicam 8mg and Paracetamol 325mg. Lornoxicam, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing prostaglandin synthesis. Paracetamol complements this action by providing effective analgesia and antipyresis through central inhibition of prostaglandin synthesis, with minimal anti-inflammatory activity. This synergistic formulation is indicated for the management of moderate to severe pain associated with musculoskeletal disorders, postoperative pain, dental pain, and other inflammatory conditions. Lornoxi P Tablet offers rapid onset of pain relief and sustained efficacy, improving patient comfort and functional ability. It is generally well tolerated; however, caution is advised in patients with a history of gastrointestinal ulcers, renal or hepatic impairment, and cardiovascular disease. Concomitant use with other NSAIDs, anticoagulants, or nephrotoxic drugs should be avoided to minimize adverse effects. Dosage should be individualized based on clinical response and patient tolerance, with adherence to recommended guidelines to ensure safety and effectiveness. Lornoxi P Tablet should be used under medical supervision to optimize therapeutic outcomes and monitor for potential side effects.